Using genetically-edited cells to supercharge the immune system caused no adverse effects in cancer patients. It’s too soon to tell if it can be a cure. It’s been over three years since US regulators greenlit the nation’s first in-human test of Crispr’s disease-fighting potential, more than three years of waiting to find out if the...
